ÂÜÀòÂÒÂ×

Dr. Yousif Sahly received his doctorate in Organic Chemistry in 1988 from the Technion, Israel Institute of Technology followed by post-doctoral training at the Massachusetts Institute of Technology. He has over 25 years of experience in large and emerging pharmaceutical companies in the USA and Israel. He has worked at Pfizer as a Director of Drug Metabolism and Pharmacokinetics and at Merck as a Senior Scientist in the Department of Drug Metabolism.

Dr. Sahly joined Teva in Israel in 2009 where he served as the Senior Director and Head of Analytical Research and Development. There he managed a department comprised of senior and associate scientists responsible for analytical method development and qualification for drug candidates of small molecules, complex mixtures (such as Copaxone), peptides, and oligonucleotides in support of formulation, chemical development, and regulatory submissions. Dr. Sahly manages both the Good Manufacturing Practice (GMP) analytical and Good Laboratory Practice (GLP) bioanalytical laboratories.